Evidence map›Paper›PMID 41020175›Full record

ArticleInternational journal of cardiology. Heart & vasculature2025

Prediction of spontaneous echo contrast following mitral valve transcatheter edge-to-edge repair.

Makoto Takeuchi, Hiroto Utsunomiya, Kiyotaka Tohgi, Ayano Hamada, Yohei Hyodo, Akane Tsuchiya, Atsuo Mogami, Hajime Takemoto, Kanako Izumi, Kosuke Takahari and 4 more

Abstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Makoto TakeuchiDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Hiroto UtsunomiyaDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Kiyotaka TohgiDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Ayano HamadaDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Yohei HyodoDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Akane TsuchiyaDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Atsuo MogamiDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Hajime TakemotoDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Kanako IzumiDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Kosuke TakahariDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Yusuke UedaDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Kiho ItakuraDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Hiroki IkenagaDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Yukiko NakanoDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although no studies predict thrombotic events after mitral valve transcatheter edge-to-edge repair (MV-TEER), 34% of patients experience worsening spontaneous echocardiographic contrast (SEC) following MV-TEER. We hypothesized that predicting the SEC occurrence or rapid progression after MV-TEER and identifying associated cases would be valuable. Methods: This retrospective study included 176 consecutive patients who underwent MV-TEER at Hiroshima University Hospital. SEC worsening was assessed using intraoperative transesophageal echocardiography pre- and post-procedure. Results: The study analyzed 168 patients undergoing MV-TEER (median age 80, 56 % male). Severe mitral regurgitation (MR), secondary MR, and atrial fibrillation were present in 67.5 %, 70.2 %, and 57.7 % (36.9 % paroxysmal) of patients, respectively. Overall, 149 patients (88 %) and 19 (12 %) had SEC grade ≤ 2 and SEC grade ≥ 3, respectively, considerably worsening post-MV-TEER in 30 %. Severe SEC or sludge (11 %) correlated with higher rates of non-paroxysmal atrial fibrillation (AF), cardiomyopathy, increased right atrial area index (RAAI), elevated atrial pressures, and reduced cardiac index. Multivariate analysis identified non-paroxysmal AF, RAAI, and preoperative SEC grade ≥ 3 as key predictors of severe SEC or sludge. Rapid SEC worsening (15 cases) was associated with non-paroxysmal AF, reduced left atrial strain, larger RAAI, and lower cardiac index. A predictive scoring model incorporating RAAI, left atrial strain, and cardiac index showed good discrimination (area under the curve: 0.79), aiding risk assessment for post-MV-TEER SEC progression. Conclusions: Patients with non-paroxysmal AF, right atrial enlargement, reduced left atrial reservoir strain, or low cardiac index are at risk of rapid SEC worsening after MV-TEER, regardless of initial SEC grades.

Indexed as

Left atrial reservoir strainMitral valve transcatheter edge-to-edge repairNon– paroxysmal atrial fibrillationRight atrial area indexSpontaneous echo contrast

Identifiers

PMID41020175
PMCPMC12464599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.